ADIPOQ and chronic kidney disease: While no direct causal mechanism has been established between adiponectin and mortality, potential pathways linking elevated adiponectin to adverse outcomes in CKD patients include protein-energy wasting syndrome, detrimental cardiovascular effects, and altered immunometabolism in the uremic milieu [18,19].